Perioperative β-Blockade: Atenolol is associated with reduced mortality when compared to metoprolol

Anesthesiology

Volumn 114, Issue 4, 2011, Pages 824-836

  Wallace, Arthur W ^a,d   Au, Selwyn ^b   Cason, Brian A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Department of Radiology   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

AGED; ARTICLE; CARDIOVASCULAR RISK; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SURGICAL MORTALITY;

EID: 79953204931     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182110e83     Document Type: Article

References (54)

1. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, Miller D, Mangano DT: Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. ANESTHESIOLOGY 1998; 88:7-17 (Pubitemid 128721126)
2. Mangano DT, Layug EL, Wallace A, Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group [published erratum appears in N Engl J Med 1997;336:1039]. N Engl J Med 1996; 335:1713-20 (Pubitemid 26399345)
3. Wallace AW, Galindez D, Salahieh A, Layug EL, Lazo EA, Haratonik KA, Boisvert DM, Kardatzke D: Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. ANESTHESIOLOGY 2004; 101:284-93 (Pubitemid 38988482)
4. Wallace A, Au S, Cason B: Association of the pattern of use of perioperative-blockade and postoperative mortality. ANESTHESIOLOGY 2010; 113:794-805
5. Celić V, Pencić B, Dekleva M, Dimković S, Kocijancić M: [Metoprolol and atenolol in mild-to-moderate chronic heart failure: Comparative study]. Srp Arh Celok Lek 2005; 133: 242-7
6. POISE Trial Investigators, Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM, Choi P, Giles JW, Yusuf S: Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: A randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 2006; 152:223-30
7. POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet 2008; 371:1839-47
8. Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Jensen G, Callesen T, Norgaard P, Fruergaard K, Bestle M, Vedelsdal R, Miran A, Jacobsen J, Roed J, Mortensen MB, Jorgensen L, Jorgensen J, Rovsing ML, Petersen PL, Pott F, Haas M, Albret R, Nielsen LL, Johansson G, Stjernholm P, Molgaard Y, Foss NB, Elkjaer J, Dehlie B, Boysen K, Zaric D, Munksgaard A, Madsen JB, Oberg B, Khanykin B, Blemmer T, Yndgaard S, Perko G, Wang LP, Winkel P, Hilden J, Jensen P, Salas N: Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: Randomised placebo controlled, blinded multicentre trial. BMJ 2006; 332: 1482
9. Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C, Diabetic Postoperative Mortality and Morbidity group: The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: Rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 2004; 147: 677-83 (Pubitemid 38900458)
10. Yang H, Raymer K, Butler R, Parlow J, Roberts R: The effects of perioperative beta-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152:983-90 (Pubitemid 44632958)
11. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM: Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group, N Engl J Med 1990; 323:1781-8
12. Mangano DT, Browner WS, Hollenberg M, Li J, Tateo IM: Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group [see comments]. JAMA 1992; 268:233-9
13. Parsons L: Using SAS software to perform a case-control match on propensity score in an observational study, Proceedings of the Twenty-Fifth Annual SAS Users Group International Conference. Cary, NC, SAS Institute Inc, 2000, pp 1166-71
14. Austin PC: A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008; 27:2037-49 (Pubitemid 351772300)
15. Pedersen TR: The Norwegian Multicenter Study of Timolol after Mycardial Infarcetion. Circulation 1983; 67:I49-53
16. Pedersen T: The Norwegian Multicenter Study on timolol after myocardial infarction-design, management and results on mortality. Acta Med Scand Suppl 1981; 651:235-41 (Pubitemid 12141592)
17. Lund-Johansen P: The Norwegian Multicenter Study on timolol after myocardial infarction: Part II. Effect in different risk groups, causes of death, heart arrest, reinfarctions, rehospitalizations and adverse experiences. Acta Med Scand Suppl 1981; 651:243-52
18. The beta-blocker heart attack trial: beta-Blocker Heart Attack Study Group. JAMA 1981; 246:2073-4
19. Beta Blocker Heart Attack Trial: Design features. Control Clin Trials 1981; 2:275-85
20. Hjalmarson A, Herlitz J, Holmberg S, Ryden L, Swedberg K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C: The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983; 67:I26-32
21. Metoprolol in acute myocardial infarction: Mortality. The MIAMI Trial Research Group. Am J Cardiol 1985; 56:15G-22G
22. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986; 2:57-66
23. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group [published erratum appears in Lancet 1988 Jul 30;2(8605):292]. Lancet 1988, 1, 921-3.
24. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Lancet 1988; 1:921-3
25. Redelmeier D, Scales D, Kopp A: Beta blockers for elective surgery in elderly patients: Population based, retrospective cohort study. BMJ 2005; 331:932
26. Nilsson OR, Atterhög JH, Castenfors J, Jorfelt L, Karlberg BE, Thulin T, Tolagen K, Wettre S, Ohman KP: A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives. Acta Med Scand 1984; 216:301-7 (Pubitemid 14024642)
27. Harron DW, Balnave K, Kinney CD, Wilson R, Russell CJ, Shanks RG: Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol. Clin Pharmacol Ther 1981; 29:295-302 (Pubitemid 11134103)
28. Morley CA, Cavalcanti C, Perrins EJ, Sutton R: A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension. Br J Clin Pharmacol 1983; 15:715-7 (Pubitemid 13099728)
29. Freestone S, Lennard MS, Silas JH, Ramsay LE: Duration of beta-blockade with metoprolol and atenolol: Influence of drug oxidation. Postgrad Med J 1983; 59(suppl 3):36-7 (Pubitemid 13022211)
30. Lyngstam O, Ryden L: Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents. Acta Med Scand 1981; 209:261-6 (Pubitemid 11105683)
31. Floris B, Paoletti G, Pelizza L, Bertulla A, Motolese M: A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: A randomized double-blind study. Int J Clin Pharmacol Ther Toxicol 1991; 29:139-43
32. Badgett RG, Lawrence VA, Cohn SL: Variations in pharmacology of beta-blockers may contribute to heterogeneous results in trials of perioperative beta-blockade. ANESTHESIOLOGY 2010; 113:585-92
33. Mannheimer B, Wettermark B, Lundberg M, Pettersson H, von Bahr C, Eliasson E: Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions. Br J Clin Pharmacol 2010; 69:411-7
34. Freestone S, Silas JH, Lennard MS, Ramsay LE: Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing. Br J Clin Pharmacol 1982; 14:713-8 (Pubitemid 13141860)
35. Wehling M: Multimorbidity and polypharmacy: That betablocker to use in relation to the pharmacokinetic profile and interaction potential. Arzneimittelforschung 2010; 60:57-63
36. Kardos A, Long V, Bryant J, Singh J, Sleight P, Casadei B: Lipophilic versus hydrophilic beta(1) blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction. Heart 1998; 79:153-60 (Pubitemid 28157335)
37. Lurje L, Wennerblom B, Tygesen H, Karlsson T, Hjalmarson A: Heart rate variability after acute myocardial infarction in patients treated with atenolol and metoprolol. Int J Cardiol 1997; 60:157-64 (Pubitemid 27304379)
38. Tuininga YS, Crijns HJ, Brouwer J, van den Berg MP, Man in't Veld AJ, Mulder G, Lie KI: Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients. Circulation 1995; 92:3415-23
39. Walle PO, Westergren G, Dimenäs E, Olofsson B, Albrektsen T: Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being. J Clin Pharmacol 1994; 34:742-7 (Pubitemid 24209370)
40. Schweizer R, Roth WT, Elbert T: Effect of two beta-blockers on stress during mental arithmetic. Psychopharmacology (Berl) 1991; 105:573-7
41. Betts TA, Alford C: Beta-blockers and sleep: A controlled trial. Eur J Clin Pharmacol 1985; 28(suppl):65-8
42. Dimenäs E, Ostergren J, Lindvall K, Dahlöf C, Westergren G, de Faire U: Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol. J Clin Pharmacol 1990; 30:S82-90 (Pubitemid 20144653)
43. Kirk CA, Cove-Smith R: A comparison between atenolol and metoprolol in respect of central nervous system side effects. Postgrad Med J 1983; 59(suppl 3):161-3 (Pubitemid 13022243)
44. Rössner S, Weiner L: Atenolol and metoprolol: Comparison of effects on blood pressure and serum lipoproteins, and side effects. Eur J Clin Pharmacol 1983; 24:573-7 (Pubitemid 13092231)
45. England JD, Simons LA, Gibson JC, Carlton M: The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man. Clin Exp Pharmacol Physiol 1980; 7:329-33 (Pubitemid 10122418)
46. Pfisterer M, Cox JL, Granger CB, Brener SJ, Naylor CD, Califf RM, van de Werf F, Stebbins AL, Lee KL, Topol EJ, Armstrong PW: Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: The GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. J Am Coll Cardiol 1998; 32: 634-40 (Pubitemid 28435246)
47. Szeto HC, Coleman RK, Gholami P, Hoffman BB, Goldstein MK: Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinic. Am J Manag Care 2002; 8:37-43 (Pubitemid 34116297)
48. Fisher SG, Weber L, Goldberg J, Davis F: Mortality ascertainment in the veteran population: Alternatives to the National Death Index. Am J Epidemiol 1995; 141:242-50
49. Nuttall GA, Houle TT: Liars, damn liars, and propensity scores. ANESTHESIOLOGY 2008; 108:3-4
50. Auroy Y, Benhamou D, Amalberti R: Time to widen our horizons in perioperative medicine: A plea in favor of using patient-centered outcomes. ANESTHESIOLOGY 2009; 110: 209-11
51. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr: ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery-Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2002; 94: 1052-64
52. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH 3rd, Spittell JA Jr, Twiss RD, Ritchie JL, Cheitlin MD, Gardner TJ, Garson A Jr, Lewis RP, Gibbons RJ, O'Rourke RA, Ryan TJ: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation 1996; 93:1278-317
53. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B: ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: Focused update on perioperative beta-blocker therapy: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation 2006; 113:2662-74
54. Fleischmann KE, Beckman JA, Buller CE, Calkins H, Fleisher LA, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Robb JF, Valentine RJ: 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120:2123-51